SOPHiA GENETICS (SOPH) Accumulated Expenses (2020 - 2025)

SOPHiA GENETICS's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $20.7 million for Q4 2025.

• In Q4 2025, Accumulated Expenses rose 56.89% year-over-year to $20.7 million; the TTM figure through Dec 2025 stood at $20.7 million (up 56.89% YoY), while the FY2025 annual figure was $20.7 million, up 56.89% from the prior year.
• Accumulated Expenses came in at $20.7 million for Q4 2025 at SOPHiA GENETICS, up from $16.7 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $20.7 million in Q4 2025 to a low of $10.5 million in Q1 2023.
• A 5-year average of $14.2 million and a median of $13.8 million in 2023 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses surged 75.88% in 2021 and plunged 31.63% in 2023, its largest moves.
• SOPHiA GENETICS's Accumulated Expenses stood at $16.0 million in 2021, then declined by 9.18% to $14.5 million in 2022, then advanced by 22.77% to $17.8 million in 2023, then declined by 25.78% to $13.2 million in 2024, then surged by 56.89% to $20.7 million in 2025.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $20.7 million, $16.7 million, and $13.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison